WO2005023855A3 - Gene et proteine k203 - Google Patents

Gene et proteine k203 Download PDF

Info

Publication number
WO2005023855A3
WO2005023855A3 PCT/EP2004/010159 EP2004010159W WO2005023855A3 WO 2005023855 A3 WO2005023855 A3 WO 2005023855A3 EP 2004010159 W EP2004010159 W EP 2004010159W WO 2005023855 A3 WO2005023855 A3 WO 2005023855A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
protein
diagnosis
cancer
present
Prior art date
Application number
PCT/EP2004/010159
Other languages
English (en)
Other versions
WO2005023855A2 (fr
Inventor
Andreas Winterpacht
Gerrit Mohrmann
Jan Georg Hengstler
Hans Will
Thomas Hofmann
Original Assignee
Friedrich Alexander Uni Versit
Univ Leipzig
Andreas Winterpacht
Gerrit Mohrmann
Jan Georg Hengstler
Hans Will
Thomas Hofmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Alexander Uni Versit, Univ Leipzig, Andreas Winterpacht, Gerrit Mohrmann, Jan Georg Hengstler, Hans Will, Thomas Hofmann filed Critical Friedrich Alexander Uni Versit
Publication of WO2005023855A2 publication Critical patent/WO2005023855A2/fr
Publication of WO2005023855A3 publication Critical patent/WO2005023855A3/fr
Priority to US11/373,761 priority Critical patent/US20060230465A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne la protéine et le gène K203 humains et murins ainsi que des composés liant K203. La présente invention porte également sur une composition pharmaceutique de diagnostic servant au diagnostic et au traitement du cancer, ainsi que sur une méthode pour diagnostiquer et traiter le cancer.
PCT/EP2004/010159 2003-09-10 2004-09-10 Gene et proteine k203 WO2005023855A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/373,761 US20060230465A1 (en) 2004-09-10 2006-03-10 K203 gene and protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50205203P 2003-09-10 2003-09-10
US60/502,052 2003-09-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/373,761 Continuation US20060230465A1 (en) 2004-09-10 2006-03-10 K203 gene and protein

Publications (2)

Publication Number Publication Date
WO2005023855A2 WO2005023855A2 (fr) 2005-03-17
WO2005023855A3 true WO2005023855A3 (fr) 2005-05-19

Family

ID=34273080

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/010159 WO2005023855A2 (fr) 2003-09-10 2004-09-10 Gene et proteine k203

Country Status (1)

Country Link
WO (1) WO2005023855A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057190A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Acides nucleiques et polypeptides
WO2001070979A2 (fr) * 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Nouveaux genes, compositions, trousses et methodes d'identification, de verification, de prevention et de traitement du cancer des ovaires
WO2004030615A2 (fr) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de tumeur

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057190A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Acides nucleiques et polypeptides
WO2001070979A2 (fr) * 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Nouveaux genes, compositions, trousses et methodes d'identification, de verification, de prevention et de traitement du cancer des ovaires
WO2004030615A2 (fr) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de tumeur

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 26 May 2002 (2002-05-26), "Mus musculus PHD finger protein 13, mRNA (cDNA clone MGC:7829 IMAGE:3500487), complete cds.", XP002309358, retrieved from EBI accession no. EM_MUS:BC029632 Database accession no. BC029632 *
DATABASE EMBL [online] 30 November 2002 (2002-11-30), "Homo sapiens PHD finger protein 13, mRNA (cDNA clone MGC:43399 IMAGE:5266750), complete cds.", XP002309356, retrieved from EBI accession no. EM_HUM:BC038516 Database accession no. BC038516 *
DATABASE Geneseq [online] 20 May 2004 (2004-05-20), "Human ovarian cancer DNA marker #20032.", XP002309355, retrieved from EBI accession no. GSN:ADL61820 Database accession no. ADL61820 *
DATABASE Geneseq [online] 6 November 2001 (2001-11-06), "Human protein SEQ ID NO 1896.", XP002309357, retrieved from EBI accession no. GSP:AAM79234 Database accession no. AAM79234 *

Also Published As

Publication number Publication date
WO2005023855A2 (fr) 2005-03-17

Similar Documents

Publication Publication Date Title
EP2006298A3 (fr) Gène de l'hémochromatose juvénile (HFE2A), produits d'expression et leurs utilisations
WO2004065423A3 (fr) Molecules de reconnaissance pour le traitement et la detection de tumeurs
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
WO2004030615A8 (fr) Compositions et procedes de diagnostic et de traitement de tumeur
EP1571968A3 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
WO2004016225A8 (fr) Compositions et methodes de diagnostic et de traitement des tumeurs
WO2004045516A9 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
DE60028970D1 (de) An her2 bindende peptidverbindungen
WO2003087831A3 (fr) Proteines impliquees dans le cancer du sein
WO2003083041A8 (fr) Anticorps specifiques au cripto
EP1571968A4 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
WO2006102504A3 (fr) Combinaisons destinees au traitement de cancer
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004060270A8 (fr) Compositions et methodes pour diagnostiquer et traiter des tumeurs
IL165950A0 (en) Compositions and method for the diagnosis and treatment of tumor
WO2003057160A8 (fr) Compositions et methodes de diagnostic et de traitement d'une tumeur
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2005003154A8 (fr) Compositions et methodes de diagnostic et de traitement de tumeur
WO2004073615A8 (fr) Composes de deazaflavine et leurs methodes d'utilisation
WO2003102185A3 (fr) Procedes et compositions pour traiter une neoplasie associee aux molecules d'acides nucleiques de a1 et a2 de hnrnp
AU2003237792A1 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004085614A3 (fr) Molecules d'acides nucleiques a regulation differentielle dans un trouble bipolaire et leurs utilisations
WO2004047757A3 (fr) Diagnostic et traitement des cancers hematopoietiques
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
WO2005023855A3 (fr) Gene et proteine k203

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11373761

Country of ref document: US

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 11373761

Country of ref document: US